WO2024230734 - K-RAS INHIBITORS AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2024/230734
Publication Date
14.11.2024
International Application No.
PCT/CN2024/091719
International Filing Date
08.05.2024
Title **
[English]
K-RAS INHIBITORS AND USE THEREOF
[French]
INHIBITEURS DE K-RAS ET LEUR UTILISATION
Applicants **
JACOBIO PHARMACEUTICALS CO., LTD.
Building 8, No. 105, Jinghai 3rd Road, Business Development Area
Tongzhou District, Beijing 100176, CN
Inventors
YANG, Hongwei
Building 8, No. 105, Jinghai 3rd Road, Business Development Area
Tongzhou District, Beijing 100176, CN
MA, Cunbo
Building 8, No. 105, Jinghai 3rd Road, Business Development Area
Tongzhou District, Beijing 100176, CN
GAO, Panliang
Building 8, No. 105, Jinghai 3rd Road, Business Development Area
Tongzhou District, Beijing 100176, CN
HAN, Huifeng
Building 8, No. 105, Jinghai 3rd Road, Business Development Area
Tongzhou District, Beijing 100176, CN
LI, Runze
Building 8, No. 105, Jinghai 3rd Road, Business Development Area
Tongzhou District, Beijing 100176, CN
WANG, Peng
Building 8, No. 105, Jinghai 3rd Road, Business Development Area
Tongzhou District, Beijing 100176, CN
WANG, Yanping
Building 8, No. 105, Jinghai 3rd Road, Business Development Area
Tongzhou District, Beijing 100176, CN
Priority Data
PCT/CN2023/097337
31.05.2023
CN
PCT/CN2023/092738
08.05.2023
CN
PCT/CN2023/094194
15.05.2023
CN
PCT/CN2023/093161
10.05.2023
CN
PCT/CN2023/093159
10.05.2023
CN
PCT/CN2023/092733
08.05.2023
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
CNIPA
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1787 | |
| EPO | Filing, Examination | 7938 | |
| Japan | Filing | 594 | |
| South Korea | Filing | 738 | |
| USA | Filing, Examination | 6760 |
Total: 17817 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The invention relates to compounds that inhibit the activity of multiple forms of K-Ras protein including K-Ras wild type and K-Ras mutant types, compositions comprising the same, and the methods of using the same.[French]
L'invention concerne des composés qui inhibent l'activité de multiples formes de protéine K-Ras y compris des types sauvages de K-Ras et des types mutants de K-Ras, des compositions les comprenant, et leurs procédés d'utilisation.